SACRED A Prospective Research Study to Reduce Stroke in Children With Sickle Cell Anemia (SACRED)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02769845

Recruitment Status : Active, not recruiting

First Posted : May 12, 2016

Last Update Posted : January 19, 2023

View this study on Beta.ClinicalTrials.gov

Sponsor:

Collaborator:

Hospital Infantil Dr. Robert Reid Cabral

Information provided by (Responsible Party):

Children's Hospital Medical Center, Cincinnati

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Actual Primary Completion Date :	July 1, 2019
Estimated Study Completion Date :	July 31, 2025

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Jeste ND, Sanchez LM, Urcuyo GS, Berges ME, Luden JP, Stuber SE, Latham TS, Mena R, Nieves RM, Ware RE. Stroke Avoidance for Children in REpublica Dominicana (SACRED): Protocol for a Prospective Study of Stroke Risk and Hydroxyurea Treatment in Sickle Cell Anemia. JMIR Res Protoc. 2017 Jun 2;6(6):e107. doi: 10.2196/resprot.7491.

To Top